Hemoglobin A1c measurement
Item
hba1c(glycosylated haemoglobin a1c <7%
boolean
C0474680 (UMLS CUI [1])
Blood pressure determination
Item
blood pressure ≤130/80 mmhg
boolean
C0005824 (UMLS CUI [1])
Low density lipoprotein cholesterol measurement
Item
ldl (low density lipoproteins) <100 mg/dl
boolean
C0202117 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Diabetic Nephropathy | Renal function GFR estimation by MDRD
Item
patients with diabetic nephropathy and estimated gfr <30ml/min with modification of diet in renal disease equation (mdrd equation)
boolean
C0011881 (UMLS CUI [1])
C2170215 (UMLS CUI [2])
Potassium measurement
Item
baseline potassium > 5.2 meq/l
boolean
C0202194 (UMLS CUI [1])
Nephrotic range proteinuria | Urine albumin/creatinine ratio measurement | Proteinuria
Item
patients with nephrotic proteinuria defined as albumine to creatinine ratio (acr)> 3.5 g/g or as proteinuria >3.5 g per 1.73 m2 per 24 hours
boolean
C0445118 (UMLS CUI [1])
C0455271 (UMLS CUI [2])
C0033687 (UMLS CUI [3])
Kidney Disease | Diabetes Mellitus Absent
Item
history or evidence of non-diabetic kidney disease
boolean
C0022658 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Cerebrovascular accident | Peripheral Arterial Diseases | Coronary Artery Disease
Item
history of stroke, peripheral artery disease, coronary artery disease
boolean
C0038454 (UMLS CUI [1])
C1704436 (UMLS CUI [2])
C1956346 (UMLS CUI [3])
Secondary hypertension
Item
history or evidence of a secondary form of hypertension
boolean
C0155616 (UMLS CUI [1])
Liver Failure Severe | Malignant Neoplasms | Endocrine System Disease Severe | Autoimmune Disease | Chronic inflammatory disorder
Item
history of severe hepatic failure, malignancy, severe endocrinopathy,autoimmune disease or chronic inflammatory disease
boolean
C0085605 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0006826 (UMLS CUI [2])
C0014130 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0004364 (UMLS CUI [4])
C1290886 (UMLS CUI [5])
Hemorrhage | Blood Platelet Disorder | Platelet Count measurement
Item
any known bleeding or platelet disorder or platelets <100.000/μl
boolean
C0019080 (UMLS CUI [1])
C0005818 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Heart failure New York Heart Association Classification
Item
heart failure in new york heart association(nyha) functional class ii-iv
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Informed Consent Unable | Informed Consent Unwilling
Item
inability or unwillingness on the part of the patient to sign the patient consent form
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Ramipril allergy | Hypersensitivity Clopidogrel
Item
known hypersensitivity to ramipril or to clopidogrel
boolean
C0571943 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0070166 (UMLS CUI [2,2])
Childbearing Potential
Item
women of child-bearing potential
boolean
C3831118 (UMLS CUI [1])
Oral anticoagulants | Antithrombotic Agents
Item
use of oral anticoagulants or other antithrombotic treatment
boolean
C0354604 (UMLS CUI [1])
C1704311 (UMLS CUI [2])
Thiazolidinediones
Item
use of glitazones
boolean
C1257987 (UMLS CUI [1])
Statins | Requirement Dose Stable
Item
patients receiving statins should be on a stable dose of at least 3 months prior to study initiation and dose should be constant during the study
boolean
C0360714 (UMLS CUI [1])
C1514873 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Surgical aspects Study Subject Participation Status At risk | Other medical condition Study Subject Participation Status At risk
Item
any surgical or medical condition which in the opinion of the investigator may expose the patient to a higher risk in participation in the study
boolean
C0038895 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])